Related references
Note: Only part of the references are listed.3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms
Zhihong Hu et al.
MODERN PATHOLOGY (2017)
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome
Sophia R. Balderman et al.
BLOOD (2016)
EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements
Michael Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The LMO2 oncogene regulates DNA replication in hematopoietic cells
Marie-Claude Sincennes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
Wei Wang et al.
BLOOD (2015)
NUP98/11p15 translocations affect CD34+cells in myeloid and T lymphoid leukemias
Barbara Crescenzi et al.
LEUKEMIA RESEARCH (2015)
The role of EVI1 in myeloid malignancies
Carolyn Glass et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression
Hiromi Yamazaki et al.
CANCER CELL (2014)
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Stefan Groeschel et al.
CELL (2014)
Identification of Regulatory Networks in HSCs and Their Immediate Progeny via Integrated Proteome, Transcriptome, and DNA Methylome Analysis
Nina Cabezas-Wallscheid et al.
CELL STEM CELL (2014)
Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation
Adlen Foudi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Infection-Induced Changes in Hematopoiesis
Arielle Glatman Zaretsky et al.
JOURNAL OF IMMUNOLOGY (2014)
Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia
Yi Zhang et al.
BLOOD (2013)
Toll-Like Receptor 4/Stem Cell Antigen 1 Signaling Promotes Hematopoietic Precursor Cell Commitment to Granulocyte Development during the Granulopoietic Response to Escherichia coli Bacteremia
Xin Shi et al.
INFECTION AND IMMUNITY (2013)
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia
Carolyn Glass et al.
PLOS ONE (2013)
The Anemia of Inflammation
Brady Lee Stein
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)
EVI1 Acts as an Inducible Negative-Feedback Regulator of NF-κB by Inhibiting p65 Acetylation
Xiangbin Xu et al.
JOURNAL OF IMMUNOLOGY (2012)
Alcohol Impairs the Myeloid Proliferative Response to Bacteremia in Mice by Inhibiting the Stem Cell Antigen-1/ERK Pathway
John Nicholas Melvan et al.
JOURNAL OF IMMUNOLOGY (2012)
Inferring rules of lineage commitment in haematopoiesis
Cristina Pina et al.
NATURE CELL BIOLOGY (2012)
Myelodysplastic Syndrome With inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Has a High Risk for Progression to Acute Myeloid Leukemia
Wei Cui et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Targeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole-Imidazole Polyamide
Yi Zhang et al.
BIOCHEMISTRY (2011)
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
Akihide Yoshimi et al.
BLOOD (2011)
PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function
Yi Zhang et al.
BLOOD (2011)
Flexible Accelerated STOP Tetracycline Operator-Knockin (FAST): A Versatile and Efficient New Gene Modulating System
Kenji F. Tanaka et al.
BIOLOGICAL PSYCHIATRY (2010)
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
Michael G. Kharas et al.
NATURE MEDICINE (2010)
EVI1 Impairs Myelopoiesis by Deregulation of PU.1 Function
Leopoldo Laricchia-Robbio et al.
CANCER RESEARCH (2009)
Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells
M. Shimabe et al.
ONCOGENE (2009)
High EVI1 levels predict adverse outcome in acute myeloid leukemia:: prevalence of EVI1 overexpression. and chromosome 3q26 abnormalities underestimated
Sanne Lugthart et al.
BLOOD (2008)
The MDS1-EVI1 gene complex as a retrovirus integration site: Impact on behavior of hematopoietic cells and implications for gene therapy
Jean-Yves Metais et al.
MOLECULAR THERAPY (2008)
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells
Hannah H. Chang et al.
NATURE (2008)
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes:: evidence from a core dataset of 2124 patients
Detlef Haase et al.
BLOOD (2007)
Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages
Yojiro Arinobu et al.
CELL STEM CELL (2007)
Ubiquitous and uniform in vivo fluorescence in ROSA26-EGFP BAC transgenic mice
Maryann Giel-Moloney et al.
GENESIS (2007)
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells
C Beard et al.
GENESIS (2006)
Identification of binding sites of EVI1 in mammalian cells
B Yatsula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation
H Iwasaki et al.
BLOOD (2005)
Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow
Y Ueda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues
K Hochedlinger et al.
CELL (2005)
Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors
SL Nutt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice
GM Cuenco et al.
ONCOGENE (2004)
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
F Rosenbauer et al.
NATURE GENETICS (2004)
High EVI1 expression predicts poor survival in acute myeloid leukemia:: a study of 319 de novo AML patients
SBV van Doorn-Khosrovani et al.
BLOOD (2003)
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates
JC Walsh et al.
IMMUNITY (2002)
Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPγ (Ig/EBP)
SE Parkin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Recombineering: A powerful new tool for mouse functional genomics
NG Copeland et al.
NATURE REVIEWS GENETICS (2001)
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
D Louz et al.
LEUKEMIA (2000)
Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production
H Nagaoka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
